Ileana Miron Yee
Family · Henderson, NVNPI 1578024642
Payments from drug & device makers
Across 178 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$896
- AbbVie$797
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$281
- Novo Nordisk$201
- Pfizer$128
- Lilly USA, LLC$125
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 43 | $896 |
| AbbVie | 40 | $797 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $281 |
| Novo Nordisk | 10 | $201 |
| Pfizer | 6 | $128 |
| Lilly USA, LLC | 8 | $125 |
| Boehringer Ingelheim | 6 | $118 |
| Novartis | 5 | $113 |
| GSK | 5 | $105 |
| Dexcom, Inc. | 5 | $102 |
| Bayer | 5 | $100 |
| Astellas Pharma US Inc | 3 | $94 |
| Exact Sciences | 4 | $70 |
| Amgen | 3 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Phadia US Inc. | 2 | $38 |
| Shield Therapeutics Inc | 1 | $37 |
| Merck | 1 | $26 |
| Radius Health, Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $24 |
| Abbott | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Intra-sana Laboratories | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Lucid Diagnostics Inc. | 1 | $17 |
How this compares
$3,655 in reported general payments places this provider in the 90th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 20 | $29,896 |
| OzempicSemaglutide | 17 | $19,212 |
| EliquisApixaban | 13 | $12,950 |
| FarxigaDapagliflozin Propanediol | 17 | $11,998 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,482 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,646 |
| Rosuvastatin Calcium | 95 | $1,334 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,170 |
| Levothyroxine Sodium | 89 | $824 |
| Losartan Potassium | 104 | $792 |
| Valsartan | 20 | $719 |
| Atorvastatin Calcium | 92 | $664 |
| Ezetimibe | 16 | $411 |
| Gabapentin | 32 | $410 |
| Metoprolol Succinate | 32 | $333 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $125 | $29,89620 claims |
| Novo NordiskOzempic | $201 | $19,21217 claims |
| AstraZenecaFarxiga, Symbicort | $896 | $14,48028 claims |
| PfizerEliquis | $128 | $12,95013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,501 family providers in Nevada.
Other family in Henderson
- Kristy SolisHenderson$23K
- Joseph LauHenderson$18K
- Judith YuHenderson$14K
- Daniel Sam AciertoHenderson$11K
- Reiko TapiaHenderson$10K
- Francis TorresHenderson$8K
- John PhoenixLas Vegas$281K
- Hollie TylerLas Vegas$118K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.